Search Results

You are looking at 181 - 190 of 500 items for :

  • Refine by Access: Content accessible to Me x
Clear All
Full access

Mark Bloomston, Henry Kaufman, John Winston, Mark Arnold, and Edward Martin

. Postoperative pain and fatigue after laparoscopic or conventional colorectal resections. A prospective randomized trial . Surg Endosc 1998 ; 12 : 1131 – 1136 . 15 Stage JG Schulze S Moller P . Prospective randomized study of laparoscopic versus

Full access

Mary S. McCabe

Survivorship Panel that is developing guidelines for the care of the cancer survivor, focusing initially on recommendations for immunizations, exercise, chronic pain, sleep disturbances, sexual issues, anxiety, depression, fatigue, and cognitive function. Each

Full access

Mary S. McCabe

Survivorship Panel that is developing guidelines for the care of the cancer survivor, focusing initially on recommendations for immunizations, exercise, chronic pain, sleep disturbances, sexual issues, anxiety, depression, fatigue, and cognitive function. Each

Full access

Michelle B. Riba, Kristine A. Donovan, Barbara Andersen, IIana Braun, William S. Breitbart, Benjamin W. Brewer, Luke O. Buchmann, Matthew M. Clark, Molly Collins, Cheyenne Corbett, Stewart Fleishman, Sofia Garcia, Donna B. Greenberg, Rev. George F. Handzo, Laura Hoofring, Chao-Hui Huang, Robin Lally, Sara Martin, Lisa McGuffey, William Mitchell, Laura J. Morrison, Megan Pailler, Oxana Palesh, Francine Parnes, Janice P. Pazar, Laurel Ralston, Jaroslava Salman, Moreen M. Shannon-Dudley, Alan D. Valentine, Nicole R. McMillian, and Susan D. Darlow

with substantial long-term side effects, such as fatigue, pain, anxiety, and depression, that interfere with patients’ ability to perform daily activities. In addition, the physiologic effects of cancer itself and certain anticancer drugs can also be

Full access

(16%), sleep disturbance (8%), fatigue (5%), cognitive changes (3%), and a general request for help (8%). Clinic staff said the questionnaire was valuable in “taking better care of the patient.” Conclusions: PROMIS GH was well accepted by patients

Full access

Presenter: Anthony Mato

also well tolerated, according to Dr. Mato, with a 1% rate of treatment discontinuation due to an AE. Common AEs included fatigue, diarrhea, neutropenia, and contusion. Grade 3 or 4 AEs were reported to be rare, and BTK inhibitor–associated events such

Full access

NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023

Featured Updates to the NCCN Guidelines

Edward M. Schaeffer, Sandy Srinivas, Nabil Adra, Yi An, Daniel Barocas, Rhonda Bitting, Alan Bryce, Brian Chapin, Heather H. Cheng, Anthony Victor D’Amico, Neil Desai, Tanya Dorff, James A. Eastham, Thomas A. Farrington, Xin Gao, Shilpa Gupta, Thomas Guzzo, Joseph E. Ippolito, Michael R. Kuettel, Joshua M. Lang, Tamara Lotan, Rana R. McKay, Todd Morgan, George Netto, Julio M. Pow-Sang, Robert Reiter, Mack Roach III, Tyler Robin, Stan Rosenfeld, Ahmad Shabsigh, Daniel Spratt, Benjamin A. Teply, Jonathan Tward, Richard Valicenti, Jessica Karen Wong, Ryan A. Berardi, Dorothy A. Shead, and Deborah A. Freedman-Cass

therapies compared with those receiving only ADT and docetaxel. The populations receiving the triplet and doublet therapies experienced similar rates neutropenia, febrile neutropenia, fatigue, and neuropathy, although grade ≥3 adverse events occurred 63% of

Full access

Presenters: James E. Bachman, Kim Slusser, Thomas K. Varghese, Andrew Wagner, and moderated by Timothy Kubal

consequences. This cannot happen overnight,” Dr. Varghese cautioned. Wellness of Healthcare Workers “With the expected tsunami of late-stage patients, we need to think about the stress and fatigue among our healthcare workers. I’m very concerned, because

Full access

Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Sam Bhayani, William P. Bro, Sam S. Chang, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Mayer Fishman, Thomas H. Gallagher, John L. Gore, Steven L. Hancock, Michael R. Harrison, Won Kim, Christos Kyriakopoulos, Chad LaGrange, Elaine T. Lam, Clayton Lau, M. Dror Michaelson, Thomas Olencki, Phillip M. Pierorazio, Elizabeth R. Plimack, Bruce G. Redman, Brian Shuch, Brad Somer, Guru Sonpavde, Jeffrey Sosman, Mary Dwyer, and Rashmi Kumar

significant). Common adverse reactions to pazopanib (any grade) included diarrhea (52%), hypertension (40%), hair color changes, nausea (26%), anorexia (22%), vomiting (21%), fatigue (19%), weakness (14%), abdominal pain (11%), and headache (10%). Notable

Full access

Casey L. O’Connell and Howard A. Liebman

, most patients with IPE actually have PE-related symptoms, such as shortness of breath or fatigue. 19 – 21 Although no prospective data exist regarding the outcome of IPE among patients with cancer, retrospective studies suggest that these thromboses